Current Approaches of Tuberculosis and Its Future Prospectives

Anamika; Assem Babbar

doi:10.55544/jrasb.2.3.36

Authors

Anamika Research Scholar, Department of Pharmacy Practice, School of Pharmaceutical Science, SGRR, University, Dehradun, INDIA.
Dr. Assem Babbar Assistant Professor, Department of Pharmacy Practice, Shri Mahant Indiresh Hospital, School of Pharmaceutical Science, SGRR, University, Dehradun, INDIA.

DOI:

https://doi.org/10.55544/jrasb.2.3.36

Keywords:

Tuberculosis, Health, Drug resistant, Treatment

Abstract

Tuberculosis is a major global health issue, with approximately 10 million people falling ill and 1.4 million dying yearly. One of the most significant challenges to public health is the emergence of drug-resistant tuberculosis. For the last half-century, treating tuberculosis has adhered to a uniform management strategy in most patients. However, treatment ineffectiveness in some individuals with pulmonary tuberculosis presents a major challenge to the global tuberculosis control initiative. Unfavorable outcomes of tuberculosis treatment (including mortality, treatment failure, loss of follow-up, and unevaluated cases) may result in increased transmission of tuberculosis and the emergence of drug-resistant strains. Treatment failure may occur due to drug-resistant strains, non-adherence to medication, inadequate absorption of drugs, or low-quality healthcare. Identifying the underlying cause and adjusting the treatment accordingly to address treatment failure is important. This is where approaches such as artificial intelligence, genetic screening, and whole genome sequencing can play a critical role. In this review, we suggest a set of particular clinical applications of these approaches, which might have the potential to influence decisions regarding the clinical management of tuberculosis patients.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Lewis, K. (2013). Platforms for antibiotic discovery. Nature reviews Drug discovery, 12(5), 371-387.

Zheng, K., Setyawati, M. I., Leong, D. T., & Xie, J. (2018). Antimicrobial silver nanomaterials. Coordination Chemistry Reviews, 357, 1-17.

Dhingra, S., Rahman, N. A. A., Peile, E., Rahman, M., Sartelli, M., Hassali, M. A., ... & Haque, M. (2020). Microbial resistance movements: an overview of global public health threats posed by antimicrobial resistance, and how best to counter. Frontiers in Public Health, 8, 535668.

Kumar, R., Saha, P., Lokare, P., Datta, K., Selvakumar, P., & Chourasia, A. (2022). A Systemic Review of Ocimum sanctum (Tulsi): Morphological Characteristics, Phytoconstituents and Therapeutic Applications. International Journal for Research in Applied Sciences and Biotechnology, 9(2), 221-226.

Menichetti, A., Mavridi-Printezi, A., Mordini, D., & Montalti, M. (2023). Effect of size, shape and surface functionalization on the antibacterial activity of silver nanoparticles. Journal of Functional Biomaterials, 14(5), 244.

Singh, A. V., Varma, M., Laux, P., Choudhary, S., Datusalia, A. K., Gupta, N., ... & Nath, B. (2023). Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review. Archives of toxicology, 97(4), 963-979.

Demain, A. L., & Sanchez, S. (2009). Microbial drug discovery: 80 years of progress. The Journal of antibiotics, 62(1), 5-16.

Lewis, K. (2013). Platforms for antibiotic discovery. Nature reviews Drug discovery, 12(5), 371-387.

Wang, X., Zhang, P., & Zhang, X. (2021). Probiotics regulate gut microbiota: an effective method to improve immunity. Molecules, 26(19), 6076.

Manandhar, S., Luitel, S., & Dahal, R. K. (2019). In vitro antimicrobial activity of some medicinal plants against human pathogenic bacteria. Journal of tropical medicine, 2019(1), 1895340.

Rudramurthy, G. R., Swamy, M. K., Sinniah, U. R., & Ghasemzadeh, A. (2016). Nanoparticles: alternatives against drug-resistant pathogenic microbes. Molecules, 21(7), 836.

Zhang, L., Pornpattananangkul, D., Hu, C. M., & Huang, C. M. (2010). Development of nanoparticles for antimicrobial drug delivery. Current medicinal chemistry, 17(6), 585-594.

Coates, A. R., Halls, G., & Hu, Y. (2011). Novel classes of antibiotics or more of the same?. British journal of pharmacology, 163(1), 184-194.

Kaur, R. P., Vasudeva, K., Kumar, R., & Munshi, A. (2018). Role of p53 gene in breast cancer: focus on mutation spectrum and therapeutic strategies. Current pharmaceutical design, 24(30), 3566-3575.

Fisher, J. F., Meroueh, S. O., & Mobashery, S. (2005). Bacterial resistance to β-lactam antibiotics: compelling opportunism, compelling opportunity. Chemical reviews, 105(2), 395-424.

Sumi, C. D., Yang, B. W., Yeo, I. C., & Hahm, Y. T. (2015). Antimicrobial peptides of the genus Bacillus: a new era for antibiotics. Canadian journal of microbiology, 61(2), 93-103.

Khan, R., Islam, B., Akram, M., Shakil, S., Ahmad, A., Ali, S. M., ... & Khan, A. U. (2009). Antimicrobial activity of five herbal extracts against multi drug resistant (MDR) strains of bacteria and fungus of clinical origin. Molecules, 14(2), 586-597.

Awuchi, C. G., Amagwula, I. O., Priya, P., Kumar, R., Yezdani, U., & Khan, M. G. (2020). Aflatoxins in foods and feeds: A review on health implications, detection, and control. Bull. Environ. Pharmacol. Life Sci, 9, 149-155.

O'Connell, K. M., Hodgkinson, J. T., Sore, H. F., Welch, M., Salmond, G. P., & Spring, D. R. (2013). Combating multidrug‐resistant bacteria: current strategies for the discovery of novel antibacterials. Angewandte Chemie International Edition, 52(41), 10706-10733.

Zhang, Y., Wade, M. M., Scorpio, A., Zhang, H., & Sun, Z. (2003). Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. Journal of antimicrobial chemotherapy, 52(5), 790-795.

Defraine, V., Fauvart, M., & Michiels, J. (2018). Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics. Drug Resistance Updates, 38, 12-26.

Sumi, C. D., Heffernan, A. J., Lipman, J., Roberts, J. A., & Sime, F. B. (2019). What antibiotic exposures are required to suppress the emergence of resistance for gram-negative bacteria? A systematic review. Clinical pharmacokinetics, 58, 1407-1443.

Fair, R. J., & Tor, Y. (2014). Antibiotics and bacterial resistance in the 21st century. Perspectives in medicinal chemistry, 6, PMC-S14459.

Lathia, J. D., Mack, S. C., Mulkearns-Hubert, E. E., Valentim, C. L., & Rich, J. N. (2015). Cancer stem cells in glioblastoma. Genes & development, 29(12), 1203-1217.

Umama, Y., Venkatajah, G., Shourabh, R., Kumar, R., Verma, A., Kumar, A., & Gayoor, M. K. (2019). Topic-The scenario of pharmaceuticals and development of microwave as; sisted extraction technique. World J Pharm Pharm Sci, 8(7), 1260-1271.

Samtiya, M., Matthews, K. R., Dhewa, T., & Puniya, A. K. (2022). Antimicrobial resistance in the food chain: trends, mechanisms, pathways, and possible regulation strategies. Foods, 11(19), 2966.

Willing, B. P., Russell, S. L., & Finlay, B. B. (2011). Shifting the balance: antibiotic effects on host–microbiota mutualism. Nature Reviews Microbiology, 9(4), 233-243.

Gérard, A., Woolfe, A., Mottet, G., Reichen, M., Castrillon, C., Menrath, V., ... & Brenan, C. (2020). High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics. Nature biotechnology, 38(6), 715-721.

Nalimu, F., Oloro, J., Kahwa, I., & Ogwang, P. E. (2021). Review on the phytochemistry and toxicological profiles of Aloe vera and Aloe ferox. Future Journal of Pharmaceutical Sciences, 7, 1-21.

Kohli, A., & Kumar, R. (2023). Role of Antioxidants of Natural Herbs in Management of Male Infertility. Journal for Research in Applied Sciences and Biotechnology, 2(1), 55-80